• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙皮肤科门诊患者中光化性角化病的患病率。

Prevalence of actinic keratosis among dermatology outpatients in Spain.

作者信息

Ferrándiz C, Plazas M J, Sabaté M, Palomino R

机构信息

Servicio de Dermotología, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.

Medical Department Spain, Almirall, Barcelona, Spain.

出版信息

Actas Dermosifiliogr. 2016 Oct;107(8):674-80. doi: 10.1016/j.ad.2016.05.016. Epub 2016 Jul 18.

DOI:10.1016/j.ad.2016.05.016
PMID:27445129
Abstract

BACKGROUND

Actinic keratoses (AKs) are common skin lesions associated with an increased risk of developing squamous cell carcinoma. Few studies in Europe have focused on AK prevalence.

AIM

To determine the point prevalence of AKs in a dermatology outpatient population in Spain, to describe the clinical characteristics of these lesions and to characterise the profile of AK patients.

METHODS

Observational, cross-sectional, multicentre study conducted in 19 hospitals (dermatology outpatient services) around Spain. A total of 204 consecutive patients per hospital who were ≥45 years old were screened for the presence of AKs.

RESULTS

3877 patients were assessed and the overall AKs prevalence was 28.6%. Prevalence was significantly higher in men than women (38.4% vs. 20.8%, p<0.0001) and increased with age for both sexes (45.2% in 71-80 years). Scalp and ear lesion locations were significantly more frequent in men (51.9% vs. 2.7% and 16.9% vs. 2.4%, respectively, p<0.0001 both cases) and the cheek, nose and neckline in women (46.3% vs. 34.0% [p<0.0001], 43.0% vs. 24.8% [p<0.0001] and 5.3% vs. 1.8% [p=0.002]). Men showed a significantly higher frequency of ≥2 affected areas than women (42.7% vs. 20.3%, p<0.0001). Among patients with AK lesions, only 65% confirmed that they were the reason for the visit to the clinic.

CONCLUSIONS

Approximately a quarter of the dermatology outpatient population in Spain aged ≥45 years old have AKs, with the prevalence rate being highest in men and in older age groups. AK is underdiagnosed and a proactive strategy is needed for the diagnosis and early treatment of these lesions.

摘要

背景

光化性角化病(AK)是常见的皮肤病变,与鳞状细胞癌发生风险增加相关。欧洲很少有研究关注AK的患病率。

目的

确定西班牙皮肤科门诊人群中AK的现患率,描述这些病变的临床特征,并对AK患者的特征进行描述。

方法

在西班牙各地的19家医院(皮肤科门诊服务)进行观察性、横断面、多中心研究。每家医院共筛选了204名年龄≥45岁的连续患者,以检查是否存在AK。

结果

共评估了3877例患者,AK的总体患病率为28.6%。男性患病率显著高于女性(38.4%对20.8%,p<0.0001),且两性患病率均随年龄增长而增加(71 - 80岁人群中为45.2%)。男性头皮和耳部病变部位明显更常见(分别为51.9%对2.7%和16.9%对2.4%,两种情况p均<0.0001),而女性的脸颊、鼻子和领口部位更常见(46.3%对34.0% [p<0.0001],43.0%对24.8% [p<0.0001],5.3%对1.8% [p = 0.002])。男性≥2个受累区域的频率显著高于女性(42.7%对20.3%,p<0.0001)。在有AK病变的患者中,只有65%确认这是他们就诊的原因。

结论

西班牙≥45岁的皮肤科门诊人群中约四分之一患有AK,患病率在男性和老年人群中最高。AK存在漏诊情况,需要采取积极策略对这些病变进行诊断和早期治疗。

相似文献

1
Prevalence of actinic keratosis among dermatology outpatients in Spain.西班牙皮肤科门诊患者中光化性角化病的患病率。
Actas Dermosifiliogr. 2016 Oct;107(8):674-80. doi: 10.1016/j.ad.2016.05.016. Epub 2016 Jul 18.
2
Prevalence of actinic keratosis among dermatology outpatients in Austria.奥地利皮肤科门诊患者中光化性角化病的患病率。
Br J Dermatol. 2014 Dec;171(6):1415-21. doi: 10.1111/bjd.13132. Epub 2014 Nov 19.
3
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.光化性角化病:丹麦皮肤科诊所疾病特征与治疗模式的横断面研究
Int J Dermatol. 2016 Mar;55(3):309-16. doi: 10.1111/ijd.12874. Epub 2015 Aug 14.
4
Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.使用氨基乙酰丙酸对面部和头皮非角化过度性光化性角化病患者进行光动力疗法:一项为期12个月随访的IV期多中心临床试验。
Br J Dermatol. 2006 Dec;155(6):1262-9. doi: 10.1111/j.1365-2133.2006.07520.x.
5
Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic.皮肤科门诊患者日光性角化病的患病率。
Medicine (Baltimore). 2019 Jul;98(28):e16465. doi: 10.1097/MD.0000000000016465.
6
Prevalence of Actinic Keratosis in Patients Attending General Practitioners in Switzerland.瑞士全科医生诊所患者中光化性角化病的患病率。
Dermatology. 2018;234(5-6):214-219. doi: 10.1159/000491820. Epub 2018 Aug 20.
7
The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China.在中国两家医院就诊的皮肤科患者中光化性角化病的患病率。
Br J Dermatol. 2016 May;174(5):1005-10. doi: 10.1111/bjd.14344. Epub 2016 Mar 31.
8
Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study.普通人群中光化性角化病的患病率及其危险因素:鹿特丹研究。
J Invest Dermatol. 2013 Aug;133(8):1971-8. doi: 10.1038/jid.2013.134. Epub 2013 Mar 19.
9
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics.意大利皮肤科诊所就诊患者日光性角化病的患病率及危险因素
Eur J Dermatol. 2017 Dec 1;27(6):599-608. doi: 10.1684/ejd.2017.3126.
10
Actinic keratoses in subjects from la Mitad del Mundo, Ecuador.来自厄瓜多尔基多世界中心地区人群的光化性角化病。
BMC Dermatol. 2020 Oct 27;20(1):11. doi: 10.1186/s12895-020-00109-8.

引用本文的文献

1
Actinic keratosis: comprehensive review of current treatments and emerging therapeutic innovations.光化性角化病:当前治疗方法及新兴治疗创新的全面综述
Postepy Dermatol Alergol. 2025 Jan 31;42(3):221-231. doi: 10.5114/ada.2024.147331. eCollection 2025 Jun.
2
Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy.光动力疗法治疗光化性角化病中增殖和炎症生物标志物(Ki67、p53和COX-2)的靶向研究
Biomedicines. 2025 Jun 17;13(6):1487. doi: 10.3390/biomedicines13061487.
3
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp.
一项随机、双盲、III期、多中心研究的长期随访,该研究旨在评估使用BF-200 ALA对比安慰剂及BF-RhodoLED®灯对轻度至中度光化性角化病进行病灶定向光动力疗法(PDT)的安全性和有效性。
J Eur Acad Dermatol Venereol. 2024 Dec 12. doi: 10.1111/jdv.20452.
4
Topical Immunotherapy for Actinic Keratosis and Field Cancerization.光化性角化病和场癌化的局部免疫疗法。
Cancers (Basel). 2024 Mar 12;16(6):1133. doi: 10.3390/cancers16061133.
5
Reflectance Confocal Microscopy and Dermoscopy of Facial Pigmented and Non-Pigmented Actinic Keratosis Features before and after Photodynamic Therapy Treatment.光动力治疗前后面部色素性和非色素性光化性角化病特征的反射式共聚焦显微镜检查和皮肤镜检查
Cancers (Basel). 2023 Nov 27;15(23):5598. doi: 10.3390/cancers15235598.
6
Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion.评估 4% 5-氟尿嘧啶乳膏治疗光化性角化病的疗效和安全性:专家意见。
Acta Derm Venereol. 2023 Nov 20;103:adv11954. doi: 10.2340/actadv.v103.11954.
7
Risk Factors for Actinic Keratoses: A Systematic Review and Meta-Analysis.光化性角化病的危险因素:一项系统评价与荟萃分析
Indian J Dermatol. 2022 Jan-Feb;67(1):92. doi: 10.4103/ijd.ijd_859_21.
8
Skin Cancer Prevalence in Outdoor Workers of Ski Resorts.滑雪胜地户外工作者的皮肤癌患病率
J Skin Cancer. 2020 Jan 28;2020:8128717. doi: 10.1155/2020/8128717. eCollection 2020.
9
Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects.光化性角化病:临床、皮肤镜及治疗方面的综述
An Bras Dermatol. 2019 Nov-Dec;94(6):637-657. doi: 10.1016/j.abd.2019.10.004. Epub 2019 Nov 6.
10
Prevalence and associated factors of skin cancer in aged nursing home residents: A multicenter prevalence study.老年护理院居民皮肤癌的患病率及相关因素:一项多中心患病率研究。
PLoS One. 2019 Apr 22;14(4):e0215379. doi: 10.1371/journal.pone.0215379. eCollection 2019.